• Mon news: Takeda layoffs. Novo’s semaglutide cardiovascular win. Roche’s Vabysmo in DME. Gilead/Merck HIV combo. Supernus quick-acting depression med. See more on our front page

Crestor only reps selling brilinta in 2013?













OMG!!!! Who is the idiot that thinks having 5 and 6 people in the same territory selling this product is a good idea? This is NOT costomer focused at all. Good God, AZ has lost their mind.
 




















Its a dog w/ CVAS & hospital. Senior leadership is desperate. This was "supposed" to be a blockbuster. They do not want to admit they were wrong on strategy and pricing.
 




Brilinta sold a whopping $10 million in the 3rd qtr.! To call it a failure would be the understatement of the century! Obviously some dumbass consultant has told AZ they need to increase their share of voice and that's why Brilinta failed. These people are completely insane! There are already to damn many reps selling Brilinta!! These idiots have no idea how to run a company!
 




OMG!!!! Who is the idiot that thinks having 5 and 6 people in the same territory selling this product is a good idea? This is NOT costomer focused at all. Good God, AZ has lost their mind.

They have lost their mind..... if Crestor primary care reps that call on cards starting making Brilinta presentations..... Customers are going flip out !!!!!!!

I don't have anything againsts the primary care reps...... the problem with Brilinta is too many people selling it.

I can't tell how confused doctors are getting and hospitals hate having multiple reps.
 








The plan is to get rid of the Symbicort/Crestor reps and leave the overlays with Crestor/Brilinta next year. Bigger territories, less reps.
The massive exodus from PC promotion has begun. Pfizer always leads the way in sales force design and they announced today that they are laying off a significant percentage of their PC sales reps and managers. How long before AZ follows their lead? The sky really is falling.